Stay updated with breaking news from Ghost Cytometry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- ThinkCyte Inc., a biotechnology company pioneering Ghost Cytometry, a proprietary AI-based, label-free cell sorting technology, today announced...
/PRNewswire/ -- ThinkCyte Inc., a biotechnology company pioneering Ghost Cytometry, a proprietary AI-based, label-free cell sorting technology, today announced...
The company aims to help the self-testing market grow by licensing its core technology for transforming smartphones into IVD devices.
The companies will develop a solution based on a new technique of flow cytometry that enables fast and accurate cell analysis using AI.
Photo by dowell/Getty Images Sysmex Corporation, a manufacturer of medical equipment and devices, has signed deals of joint development and investment with biotechnology startup ThinkCyte for the production and sale of a new artificial intelligence-enabled cell analysis technology for in-vitro diagnostics. WHAT IT'S FOR Sysmex has been acquiring technologies for analysing cells, genes, and proteins with a high degree of precision and sensitivity. It chose to collaborate with ThinkCyte as it possesses a new technique of flow cytometry – the method of detecting and measuring physical and chem...